By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Infinity Pharmaceuticals Inc. 

780 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-453-1000 Fax: 617-453-1001

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation.

Small molecule discovery and development capabilities
Infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation.

Strategic alliances
Building on its strengths in innovative small molecule drug discovery and development, Infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline.

Business and scientific expertise
The company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business and drug discovery and development.

Culture of Citizen-Ownership
Infinity’s culture and environment of Citizen-Ownership is as important as its technologies. Infinity works together as a community with the shared goal of bringing important new medicines to patients.

Key Statistics

Ownership: Public

Web Site: Infinity Pharmaceuticals Inc.
Employees: 180
Symbol: INFI



Company News
Infinity Pharmaceuticals Inc. (INFI) To Present At Deutsche Bank (DB) Securities 2014 BioFEST Conference 11/24/2014 10:40:55 AM
Infinity Pharmaceuticals Inc. (INFI) Reports Third Quarter 2014 Financial Results And Provides Company Update 11/7/2014 9:11:49 AM
Infinity Pharmaceuticals Inc. (INFI) Announces Clinical And Preclincal Data For Duvelisib To Be Presented At American Society of Hematology 2014 Annual Meeting 11/6/2014 11:35:52 AM
Infinity Pharmaceuticals Inc. (INFI) To Participate In Four Conferences In November 10/30/2014 10:10:07 AM
Infinity Pharmaceuticals Inc. (INFI) Announces The Date Of Its Third Quarter 2014 Financial Results Conference Call And Webcast 10/23/2014 11:41:09 AM
Infinity Pharmaceuticals Inc. (INFI) Reports Topline Data From Phase 2a Exploratory Study Of Duvelisib In Patients With Mild, Allergic Asthma 10/16/2014 10:37:54 AM
Infinity Pharmaceuticals Inc. (INFI) Enters Into Master Clinical Supply Agreement And Material Transfer Agreement With Roche (RHHBY) 9/3/2014 12:40:25 PM
AbbVie (ABBV) Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc. (INFI)’s Blood Cancer Drug; Deal Could Be Worth $805 Million 9/3/2014 6:20:46 AM
Infinity Pharmaceuticals Inc. (INFI) To Participate In Two Conferences In September 8/27/2014 8:58:48 AM
Infinity Pharmaceuticals Inc. (INFI) Amends PI3K-Delta, Gamma Agreement With Millennium 8/5/2014 10:06:14 AM